Joanna Nowacka joins Dynamic42 as Lead for Stem Cell Model Development
We are delighted to announce that Joanna Nowacka has recently joined Dynamic42 as a scientist. Joanna is from Warsaw in Poland and brings along a remarkable background in biotechnology, having graduated summa cum laude from the University of Warsaw. Her scientist journey includes two notable internships in the USA at the Dana-Farber Cancer Institute and the University of Virginia, further enhancing her expertise in cancer research and biotechnology. We are very happy to have Joanna support our research team.
Embracing the future of Drug Testing Models
Currently, Joanna finished her industrial Ph.D. project in Miltenyi Biotec with the affiliation at the University of Tübingen. This project, as part of the prestigious Marie-Skłodowska-Curie Actions program, focused on developing innovative heart-on-a-chip for applications in cellular therapies. This multidisciplinary experience perfectly aligns with Dynamic42’s cutting-edge research and development initiatives. In the context of personalized medicine, Joanna will develop stem cell cultures into “pluripotent” stem cells. From this, each type of cell can then be distinguished.
I believe organ-on-chip technology represents the future of drug testing models. I am eager to join Dynamic42 to contribute my stem cell expertise to their already remarkable platforms.
Beyond the Lab
In her free time, Joanna enjoys immersing herself in various activities. She likes reading, finds creativity in knitting, and experiments with new cooking recipes.
Read more News:
Press Release | Biotech company Dynamic42 launches open platform for organ model development
Dynamic42 has launched the “DynamicOrgan System”, an open, flexible, and cost-effective organ-on-chip platform for lab use.
Mari Kakihara joins Dynamic42 to support Finance and Controlling
We are excited to announce that Mari Kakihara has joined us recently to support Finance and Controlling.
Press Release | The Dynamic42 3D intestinal chip model takes research of fungal infections to a new level
Dynamic42 GmbH has developed an intestine-on-chip candidiasis model that allows for the quantification of the infection process.